Iorio, Ronald M.; Syddall, Richard J.; Sheehan, John P.; Bratt, Michael A.; Glickman, Rhona L.; and Riel, Anne M., "Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition" (1991). Open Access Articles. 1570.
The hemagglutinin-neuraminidase (HN) glycoprotein of Newcastle disease virus (NDV) possesses both the receptor recognition and neuraminidase (NA) activities associated with the virus. In virions, HN is found as spikes protruding from the cellularly derived viral membrane, in which it is anchored near its amino terminus (33) .
The amino acid sequences of the HN glycoproteins of several NDV isolates have been deduced from the nucleotide sequences of cloned genes (20, 23, 24, 31, 32) . There is extensive amino acid homology between the HN glycoproteins of the different isolates, approximately 90% in any pair-wise comparison (29) . Each has a hydrophobic stretch of amino acids near its amino terminus that is presumed to be the membrane-spanning domain. Six potential asparaginelinked glycosylation sites, predominantly in the carboxyterminal half of the molecule, are also highly conserved in the HN of most of the isolates (29) .
There is also extensive conservation of the number and position of cysteine residues among the HN sequences of different NDV isolates. Twelve of the 13 cysteine residues carboxy terminal to the proposed membrane-spanning region are conserved. Only the cysteine at residue 123 is conspicuous by its absence in the majority of the NDV isolates sequenced thus far (34) . This is probably causally related to the observation that the HN of NDV apparently can exist in virions in either a disulfide-linked or a nondisulfide-linked form, depending on the isolate, but does not appear to be associated with any obvious difference in HN function or antigenic structure (25, 27, 35) . The presence of cysteine at residue 123 correlates with the existence of disulfide-linked dimeric HN in virions, implicating this cys-* Corresponding author. teine in intermolecular disulfide bonding between HN monomers.
We initially characterized a panel of monoclonal antibodies (MAbs) to antigenic sites 1, 2, 3, and 4 on the surface of the HN glycoprotein of the AV isolate (13) . However, many MAbs produced by hybridomas isolated in subsequent fusions were shown to map to sites which overlap two of the original four sites and were named to reflect this, hence sites 12, 14, and 23 (12, 18) . Since any one site overlaps at least one other in competition antibody binding assays, our panel of MAbs recognizes seven overlapping antigenic sites which form a linked continuum (sites 4-14-1-12-2-23-3) on the surface of the molecule. Functional inhibition studies revealed that MAbs to three overlapping sites (12, 2, and 23) inhibit the NA activity of the virus (12, 18) . However, analysis of variants, as well as other studies, indicated that site 23 is probably closest to the actual NA site (19) . MAbs to these three sites, as well as those to sites 1 and 14, inhibit hemagglutination (HA) (12, 14) and neutralize predominantly by preventing viral attachment to chick cells (18) . MAbs to the two remaining sites (3 and 4) inhibit neither HA-attachment nor NA but do inhibit the hemolytic activity of the virus (14) and presumably neutralize at a postattachment step.
We selected and characterized a variety of antigenic variants which escape neutralization by an antibody to each of the five sites on HN involved in viral attachment. Individual amino acid substitutions were identified in the HN proteins of these variants, making it possible to construct a map of the neutralizing domains of HN and providing insight into its three-dimensional structure. These substitutions clustered in three domains of the molecule. One domain (amino acid residues 193 to 201) is part of a more extensive region (171 to 205) previously implicated in the NA activity of HN (19) . The remaining two regions include (i) residues 5000 IORIO ET AL.
345 to 353 and (ii) residues 513 to 521 plus 494 and 569. The former of these is a linear epitope which coincides with one recognized in another NDV isolate by MAbs which also inhibit HA (30) .
Amino acid substitution in the attachment site on HN could influence the receptor recognition properties of the virus. Periodate treatment oxidizes the sialic acid moieties on the surface of erythrocytes, rendering them resistant to agglutination by viruses that recognize a sialic acid-containing receptor (37) . Thus, substitution at amino acid residues important to the recognition of cellular receptors might be expected to alter the sensitivity of the virus-erythrocyte interaction to periodate treatment. This was shown to be the case for MAb-selected variants of influenza virus (38) . We show here that a substitution at position 193 of the HN of the AV isolate renders the HA activity of the virus almost threefold more resistant to periodate treatment of chicken erythrocytes, indicating that this residue influences receptor recognition.
MATERIALS AND METHODS
Virus. The Australia-Victoria (1932) (AV) isolate of NDV, as well as variants and revertants derived from it, and the Illinois-Great Lakes (GL) (1953) and Mexico-Texcoco (MT) (1950) isolates were grown in the allantoic sacs of 10-day-old embryonated hen eggs at 37°C from a stock of virus one egg passage from cloning (2) . After the death of the majority of the embryos, allantoic fluid was harvested and virus was purified as described previously (4, 41) .
Cell culture. Primary and secondary chicken embryo cells were prepared and maintained as described previously (2, 41) . Confluent secondary cultures in 60-mm tissue culture dishes were used for plaque assays.
Hybridomas and MAbs. The preparation of hybridomas and the initial characterization of MAbs have been described previously (12, 13, 18) .
Selection of variants and isolation of revertants. Variants were selected from cloned, passaged stocks of AV by escape from neutralizing MAb, using rabbit anti-mouse immunoglobulin (16 (18) . The ability of MAbs to block viral infectivity was determined in a plaque neutralization assay (15) . Rabbit anti-mouse immunoglobulin treatment (16) was used to verify binding by those MAbs which did not result in neutralization.
Primer extension and dideoxy sequencing. The nucleotide sequence of the entire HN gene of each variant and revertant was determined by using 17-mer oligonucleotides complementary to that of the AV isolate (23) to prime dideoxynucleotide chain termination-sequencing reactions. The primers, their purification, the primer extension reactions, and the sequencing gel protocols have all been described previously (34) , as has the preparation of virion RNA template (19 were incubated for 30 min at room temperature with 0.1 volume of various concentrations (0.5 to 10 mM) of freshly prepared sodium metaperiodate. A 0.1 volume of 40% glucose was added to stop periodate oxidation before use of the erythrocytes in an HA assay (19) . The concentration of periodate which decreased the HA activity of each virus by 4 HA units was determined.
Amino acid sequence homology and hydrophilicity profile. The HN amino acid sequences of different paramyxoviruses were aligned by using the DNASTAR Align program. The published nucleotide sequence of the HN gene of the AV isolate of NDV (23) predicted a protein of 570 amino acids lacking the tyrosine at residue 184 of other isolates (20, 24) . We have since found that this tyrosine residue is, indeed, present in the HN of the AV isolate (data not shown). This eliminates the need to insert a space in the AV sequence at this position to achieve maximum alignment (19) . Previously published variant amino acid substitutions, all of which are carboxy terminal to residue 184 (19) , have been renumbered (plus 1) in this report.
Secondary structure was predicted by the method of Chou not recognized by the MAb; (ii) neutralization similar to the wild-type virus; and (iii) recognition, but ineffective neutralization, of the variant by the MAb. In the last case, binding was verified by ELISA or by enhanced neutralization mediated by the addition of anti-immunoglobulin. Examples of antibody binding to virions without neutralization include several MAbs to site 14 and variants 14a-8 and 14C-1 (Fig. 1); some of the site 23 MAbs and variants 23a-3 and 23f1 (19); and the site 2 MAbs and variant 2a-1 (16) .
Variant 2a-1 is temperature sensitive for plaque formation (17) . Two revertants of this variant, 2a-lR6 and 2a-1R11, formed plaques at the nonpermissive temperature of 41.8°C. These viruses also reverted for neutralization by the selecting antibody, 2a.
Two of the site 14 variants, 14C-1 (Fig. 1 The three domains are all in hydrophilic regions of the molecule. The localization of the three domains recognized by MAbs that prevent attachment relative to the hydrophilicity profile of HN showed that the region of the molecule recognized by site 14 and 1 MAbs (residues 345, 347, 350, and 353) aligns with the broadest peak of hydrophilicity in the linear amino acid sequence of HN (Fig. 2) . Similarly, the remaining two domains also coincide with peaks of hydrophilicity, but both are much sharper peaks centered around residues 199 (site 23) and 516 (sites 12 and 2), respectively. The hydrophilic regions around residues 258 and 279 coincide with determinants recognized by MAbs which do not block attachment (data not shown). None of the MAbs to the HN glycoproteins of any of the paramyxoviruses selected a variant with a substitution coinciding with the remaining hydrophilic peak. This peak represents the 234-NRKSCS-239 sequence that is completely conserved among the Paramyxoviridae (26 the major regions of HN predicted to be exposed at the surface of the molecule.
MAbs to site 14 recognize a continuous epitope. To determine whether any of the antibody-binding epitopes recognized by these antibodies is a continuous determinant, we assayed MAbs to each of the five sites for their ability to recognize denatured HN. Figure 3 shows that site 14 MAbs (except 14a) very efficiently recognized the non-disulfidelinked monomeric form produced by boiling and reducing HN, suggesting that they bind to a continuous epitope in the sequence of HN. In contrast, MAbs to sites 12 and 23 could not be shown to recognize boiled, reduced HN even after a 20-fold longer exposure (Fig. 3, lanes 2 to 6) . MAb 14a had a distinctly different pattern of reactivity with the site 14 variants compared with the other site 14 MAbs (Fig. 1) and bound comparatively weakly in the Western blots (Fig. 3, lane 7) , also requiring a significantly longer exposure for even weak detection. This suggests that 14a binds to an epitope that is slightly more dependent on conformation than those recognized by the other site 14 MAbs. This may be related to the fact that one of its variants, 14a-7' has a second substitution outside the domain defining site 14.
We tried to further define site 14 through the use of synthetic peptides corresponding to affinity that pretreatment of the MAbs with the peptides they recognized could protect the virus from neutralization by the MAb (Fig. 5) . Consistent with the ELISA data (Fig. 4) , only peptides corresponding to HN residues 336 to 355 and 341 to 355 were protective. Furthermore, neither protected the virus from MAbs to other domains, e.g., site 1 (Fig. 5) , which topologically overlaps site 14.
Effect of periodate treatment of erythrocytes on HA by variants. Each of the variants was assayed for its ability to agglutinate chicken erythrocytes pretreated with increasing concentrations of periodate to try to identify an amino acid substitution(s) in HN that influences receptor recognition. The results of the periodate sensitivity test are shown in Fig.  6 . The concentration of periodate which decreases by 4 units the HA activity of each variant is related to that which similarly decreases the HA activity of the wild type, which is set at unity. Variant 55D7-5, selected with an MAb to the F glycoprotein, and a variant (3a-1), selected with an MAb to HN that does not prevent viral attachment to the host cell (18) , served as controls and did not differ significantly from the wild type in their periodate sensitivity.
The variant with the most significant alteration in periodate sensitivity was 23a-3, which had a single amino acid substitution of leucine for the phenylalanine present at residue 193 of the wild type. This substitution rendered receptor recognition nearly threefold more resistant to periodate treatment of erythrocytes than the wild-type HN, indicating that the residue at this position strongly influences receptor recognition.
Of five NDV isolates for which the sequence of the HN gene is known, only AV has a phenylalanine residue at position 193 (19) . The majority of the others have leucine at this position. Application of the periodate sensitivity test to two other NDV isolates (MT and GL), which also have leucine at position 193 (data not shown), indicated that they have a level of resistance to periodate similar to that of variant 23a-3 (Fig. 6 ). These findings suggest that the amino acid residue at position 193 of HN influences receptor recognition by NDV.
Several other variants, most notably 23a-1, lb-2, lc-1, 2a-3 and 12e-2, showed decreased resistance to periodate relative to the wild type (Fig. 6) . However, unlike 23a-3, no counterpart in naturally occurring isolates was found, since each of the amino acid residues substituted for in the above variants is, as far as is known, conserved throughout the NDV serotype (29 12 and that sites 12 and 2 partially overlap site 23 (18) . Thus, these three regions are brought together at the surface of the molecule, presumably near its receptor recognition site. This suggests that the receptor-binding site on HN is probably also defined by noncontiguous regions of the molecule brought together in the native structure. These findings are consistent with those from similar studies of the antigenic structure of the attachment proteins of other paramyxoviruses such as Sendai virus (36) (Fig. 8) . It is possible that the relationship between these antigenic sites and the receptor recognition site in the HN of NDV is similar to that in the hemagglutinin of influenza virus. X-ray crystallographic studies of the structure of the latter protein complexed with cell receptor analogs show sialic acid bound in a pocket in the molecule surrounded by antibody-binding sites (40) . This gives the virus a means to escape from neutralizing antibody, yet retain its receptor recognition site.
With our findings concerning the site 1 and 14 MAbs and those obtained with the Beaudette (30, 42) and D26 (10, 28) isolates of NDV, three groups (30, 42) .
Unlike the other HN antigenic sites, that defined by HN residues 193 to 201 (our site 23) showed a significant degree of conservation among the paramyxoviruses (Fig. 8) . Residues 195, 196, 198 , and 199 were almost completely conserved throughout the group. When one broadens the comparison (residues 171 to 206) to include residues on either side of those known to contribute to the site 23 epitope, an even more remarkable degree of conservation is revealed (19) .
Previous studies have revealed that this domain is also directly involved in the NA activity of HN. Substitution at residue 194 or 201 results in markedly altered NA (19) but, as shown here, had no significant effect on sensitivity to periodate treatment of erythrocytes (Fig. 6 ). On the other hand, although substitution at HN residue 193 (variant 23a-3) has no effect on NA activity (19) , the relative periodate resistance resulting from a substitution of leucine for the phenylalanine at residue 193 of the HN of the AV isolate indicates that this residue is probably directly involved in receptor recognition. Thus, the site 23 domain includes residues involved in both functions of the molecule, and substitution within the domain differentially affects the attachment and NA activities of the protein. This speaks to the long-debated question of whether or not the attachment and NA sites on HN are separate. Certainly, a great deal of evidence now exists to support the notion that the two sites are separable (reviewed in reference 19). However, the stretch of amino acids from residues 193 to 201 is clearly involved in both functions, so the two active sites probably overlap to a certain extent. Confirmation of this awaits the solution of the three-dimensional structure of the protein.
The isolation of variants which are not neutralized by the selecting MAb but retain the ability to bind that antibody adequately enough to ensure that the addition of antiimmunoglobulin can effect neutralization has also been described for antibodies to the hemagglutinin of influenza A viruses (9) . In fact, in both that system and NDV (17) 
